Citro, Salvatore http://orcid.org/0000-0001-5222-6501
Lazzaro, Giulia Di http://orcid.org/0000-0003-2413-1788
Cimmino, Angelo Tiziano http://orcid.org/0000-0001-9298-565X
Giuffrè, Guido Maria
Marra, Camillo
Calabresi, Paolo http://orcid.org/0000-0003-0326-5509
Article History
Accepted: 9 November 2023
First Online: 5 December 2023
Competing interests
: P.C. received/receives research support, speaker honoraria, and support to attend national and international conferences (not related to the present study) from Abbvie, Bayer Schering, Bial, Biogen-Dompè, Biogen-Idec, Eisai, Lilly, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Sanofi-Genzyme, Teva, UCB Pharma and Zambon. The other authors reported no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the last 12 months, biomedical financial interests or potential conflicts of interest.